|
Volumn 52, Issue 3, 2012, Pages 193-198
|
Successful treatment of immunodeficiency-associated EBV-negative lymphoproliferative disorders in rheumatoid arthritis by methotrexate withdrawal and prevention of its relapse by rituximab administration.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC ANTIMETABOLITE;
ANTIRHEUMATIC AGENT;
METHOTREXATE;
MONOCLONAL ANTIBODY;
RITUXIMAB;
ARTICLE;
CASE REPORT;
DISEASE FREE SURVIVAL;
DRUG ADMINISTRATION;
EPSTEIN BARR VIRUS;
HUMAN;
IMMUNE DEFICIENCY;
IMMUNOLOGY;
LARGE CELL LYMPHOMA;
MALE;
MIDDLE AGED;
RECURRENT DISEASE;
RHEUMATOID ARTHRITIS;
ANTIBODIES, MONOCLONAL, MURINE-DERIVED;
ANTIMETABOLITES, ANTINEOPLASTIC;
ANTIRHEUMATIC AGENTS;
ARTHRITIS, RHEUMATOID;
DISEASE-FREE SURVIVAL;
DRUG ADMINISTRATION SCHEDULE;
HERPESVIRUS 4, HUMAN;
HUMANS;
IMMUNOLOGIC DEFICIENCY SYNDROMES;
LYMPHOMA, LARGE B-CELL, DIFFUSE;
MALE;
METHOTREXATE;
MIDDLE AGED;
RECURRENCE;
|
EID: 84878387209
PISSN: None
EISSN: 18809952
Source Type: Journal
DOI: 10.3960/jslrt.52.193 Document Type: Article |
Times cited : (10)
|
References (0)
|